![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 2
Zeitschriftenartikel
Wang, Michael L.; Jurczak, Wojciech; Jerkeman, Mats; Trotman, Judith; Zinzani, Pier L.; Belada, David; Boccomini, Carola; Flinn, Ian W.; Giri, Pratyush; Goy, Andre; Hamlin, Paul A.; Hermine, Olivier; Hernandez-Rivas, Jose-Angel; Hong, Xiaonan; Kim, Seok Jin; Lewis, David; Mishima, Yuko; Ozcan, Muhit; Perini, Guilherme F.; Pocock, Christopher; Song, Yuqin; Spurgeon, Stephen E.; Storring, John M.; Walewski, Jan; Zhu, Jun; Qin, Rui; Henninger, Todd; Deshpande, Sanjay; Howes, Angela; Le Gouill, Steven und Dreyling, Martin
(2022):
Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma.
In: New England Journal of Medicine, Bd. 386, Nr. 26: S. 2482-2494
Brown, Jennifer R.; Moslehi, Javid; O'Brien, Susan; Ghia, Paolo; Hillmen, Peter; Cymbalista, Florence; Shanafelt, Tait D.; Fraser, Graeme; Rule, Simon; Kipps, Thomas J.; Coutre, Steven; Dilhuydy, Marie-Sarah; Cramer, Paula; Tedeschi, Alessandra; Jäger, Ulrich; Dreyling, Martin; Byrd, John C.; Howes, Angela; Todd, Michael; Vermeulen, Jessica; James, Danelle F.; Clow, Fong; Styles, Lori; Valentino, Rudy; Wildgust, Mark; Mahler, Michelle und Burger, Jan A.
(2017):
Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials.
In: Haematologica, Bd. 102, Nr. 10: S. 1796-1805